AE Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,480
Closed -$302K 2040
2023
Q4
$302K Sell
2,480
-645
-21% -$72K ﹤0.01% 1695
2023
Q3
$351K Sell
3,125
-12,490
-80% -$1.59M ﹤0.01% 1540
2023
Q2
$2.27M Sell
15,615
-5,709
-27% -$776K 0.01% 809
2023
Q1
$2.76M Buy
+21,324
New +$2.68M 0.02% 687
2022
Q3
Sell
-1,916
Closed -$201K 1894
2022
Q2
$201K Sell
1,916
-219
-10% -$26K ﹤0.01% 1599
2022
Q1
$273K Sell
2,135
-531
-20% -$64K ﹤0.01% 1458
2021
Q4
$329K Sell
2,666
-22,598
-89% -$2.96M ﹤0.01% 1410
2021
Q3
$3.59M Sell
25,264
-2,116
-8% -$311K 0.03% 460
2021
Q2
$4.28M Buy
27,380
+2,335
+9% +$378K 0.04% 414
2021
Q1
$3.89M Buy
25,045
+6,188
+33% +$959K 0.04% 373
2020
Q4
$2.82M Buy
18,857
+1,246
+7% +$176K 0.03% 398
2020
Q3
$2.33M Buy
17,611
+3,166
+22% +$414K 0.03% 386
2020
Q2
$1.67M Buy
14,445
+7,212
+100% +$831K 0.03% 463
2020
Q1
$710K Buy
+7,233
New +$948K 0.02% 574

Other funds holding ZBH

AE Wealth Management's ZBH Position: Q1 2024 in Review

AE Wealth Management sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 2,480 shares — an estimated $302K sold.

AE Wealth Management first reported a position in ZBH in Q1 2020 and held it in 14 quarters. The position peaked at $4.28M in Q2 2021. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • AE Wealth Management reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • AE Wealth Management sold 2,480 Zimmer Biomet shares in Q1 2024, an estimated $302K.
  • AE Wealth Management first reported a position in Zimmer Biomet in Q1 2020 and held it in 14 quarters.
  • AE Wealth Management's Zimmer Biomet position peaked at $4.28M in Q2 2021.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on AE Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.